Quality of web-based oncology guidelines "modest"
AASLD updates guidelines for genotype 1 chronic HCV
Americans make risky healthcare trade-offs to save money
New HIV treatment guidelines: a focus on comorbid conditions
Shifting costs to beneficiaries may not save costs in long run
Nearly one in four adult paracetamol users are receiving more than the maximum daily recommended dose of 4 g/day
Will NHS personal health budgets = better care?
Adding cetuximab to RT: ahead for cost effectiveness in Taiwan
Cost effectiveness of ICDs just off the beat in Germany
Combined patient and GP training best for BP control in Pakistan
Oral estrogen therapy prescribed more than transdermal
Additional risk factors add to cost of AF in the USA
Influenza vax coverage varies in US healthcare workers ...
Everolimus cost effective for mRCC after sunitinib failure
Cost of US health coverage per employee on the increase
One-third of neonates not given birth dose of HBV vaccine
Infant rotavirus vax would be "very cost-effective" for Armenia
MRSA decolonisation strategies cost effective in the ICU
New HCV treatments mean more patients to treat in France
Second-line lanthanum carbonate best regardless of dialysis status
Palivizumab: a performer for prevention of RSV in Austria
Gastric cancer: trastuzumab cost effective for some, but not all
Pradaxa: convenience comes at a high cost
Poor antiretroviral taste leads to non-compliance in paediatrics
Insulin detemir more cost effective than NPH?
Second generation pneumococcal vaccines: which is best in Norway?
Is vaccinating adult women against HPV worth it in the Netherlands?
Tamsulosin and dutasteride: winning combination for BPH?
Cytisine, a low-cost, effective smoking cessation therapy, may be an attractive option for low- and middle-income countries,
What strategy can lighten the load of pressure ulcers?
Better QOL with sequential docetaxel and carboplatin
Botox injects meaningful improvements into QOL
Eisai to appeal SMC's decision not to recommend Halaven
Abbott dominates declining stent market
Apotex has announced its successful patent challenge, allowing the delivery of a generic alternative to Xalatan [latanoprost] in Canada.
The Global Fund for AIDS, Tuberculosis and Malaria has rejected the US's request for an emergency grant of $US50 million
Telaprevir, boceprevir: scripts continue to climb in US
Free universal healthcare coverage for India?
The US wound and tissue management market is tipped to exceed $US10.4 billion by 2018,